Allogene Therapeutics, Inc. (NASDAQ:ALLO) IPO
IPO
Priced at US$18.00 a share on Oct 10, 2018.
- Price
- US$18.00 a share
- Shares offered
- 18,000,000 shares of common stock
- Offering size
- US$324 million
- Underwriters' option
- Up to 2,700,000 more shares
- Underwriters
- Goldman Sachs & Co. LLC, J.P. Morgan, Cowen, Jefferies · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Aug 10, 2018 |
| Filed publicly | Sep 14, 2018 |
| Amended 3 times | Newest Oct 5, 2018 |
| Shares registered with an exchange | Oct 5, 2018 |
| Declared effective by the SEC | Oct 10, 2018 |
| Final prospectus, with the price | Oct 11, 2018 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 11, 2018 |
| EFFECT · Notice that a registration is effective | Oct 10, 2018 |
| S-1MEF · Registration of more shares for the same offering | Oct 10, 2018 |
| CERT · Exchange's certificate of listing | Oct 10, 2018 |
| 8-A12B · Registration of shares for listing on an exchange | Oct 5, 2018 |
| S-1/A · Registration statement, amended | Oct 5, 2018 |
| CORRESP · Letter to the SEC | Oct 4, 2018 |
| CORRESP · Letter to the SEC | Oct 4, 2018 |
| CORRESP · Letter to the SEC | Oct 2, 2018 |
| S-1/A · Registration statement, amended | Oct 2, 2018 |
| UPLOAD · Letter from the SEC | Sep 26, 2018 |
| CORRESP · Letter to the SEC | Sep 26, 2018 |
| S-1/A · Registration statement, amended | Sep 17, 2018 |
| CORRESP · Letter to the SEC | Sep 14, 2018 |
| S-1 · Registration statement | Sep 14, 2018 |
| UPLOAD · Letter from the SEC | Sep 11, 2018 |
| DRS · Draft registration statement | Aug 10, 2018 |
From the cover of the final prospectus (424B4) filed Oct 11, 2018